Recruiting OBSERVATIONAL NCT06154382

Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit

Eltroxin Administration to Patients With Extremely Low T4 Values in the Intensive Care Unit: Comparison Between Groups and Therapeutic Outcomes

Sponsor: Meir Medical Center

Conditions Thyroid; Functional Disturbance

Interventions Eltroxin administration

Updated 5 times since 2024 Last updated: May 7, 2025 Started: Jun 1, 2024 Primary completion: Feb 1, 2026 Completion: Feb 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06154382, this observational or N/A phase trial focuses on Thyroid; Functional Disturbance and remains actively recruiting participants. Sponsored by Meir Medical Center, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Jun 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Apr 2024 — Jul 2024 [monthly]

Not Yet Recruiting
Jan 2024 — Apr 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meir Medical Center

Data source: Meir Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kfar Saba, Israel